Morgan Stanley has revised its price target for Procter & Gamble (PG, Financial), decreasing it to $180 from the previous $191. Despite this adjustment, the analyst maintained an Overweight rating on its shares. The change follows a third fiscal quarter marked by modest organic sales growth, influenced by U.S. retailer inventory reductions and subdued earnings per share (EPS) guidance due to a soft topline and additional tariffs.
In light of these developments, Morgan Stanley has also reduced its EPS estimate for fiscal year 2026 by 3%. However, the firm remains optimistic about the company's future. It anticipates a resurgence in organic sales growth, expecting it to climb to 2%-3%. Although recent EPS revisions negatively impacted expectations, the firm believes these adjustments have now been fully reflected in the stock's performance.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 25 analysts, the average target price for Procter & Gamble Co (PG, Financial) is $176.49 with a high estimate of $200.00 and a low estimate of $144.22. The average target implies an upside of 10.63% from the current price of $159.53. More detailed estimate data can be found on the Procter & Gamble Co (PG) Forecast page.
Based on the consensus recommendation from 29 brokerage firms, Procter & Gamble Co's (PG, Financial) average brokerage recommendation is currently 2.2, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Procter & Gamble Co (PG, Financial) in one year is $166.75, suggesting a upside of 4.53% from the current price of $159.53. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Procter & Gamble Co (PG) Summary page.
